Peter Geschek
Long only

Acadia: The Best Hope For Parkinson's Psychosis Sufferers

One of the most distressing symptoms of Parkinson's disease is the psychosis which causes people to have hallucinations and delusions. It is a quite common condition which affects about 40 percent of all patients with Parkinson's disease. And the number of Parkinson's patients is growing rapidly along with the increase of the elderly population.

There is no FDA approved drug for Parkinson's psychosis.

Acadia Pharmaceuticals' (NASDAQ:ACAD) promising new drug, Pimavanserin is expected to be submitted for approval at the end of 2014 and possibly begin producing revenue from 2015.

Acadia, located in San Diego, California, is a small company with less than 50 employees.

Pimavanserin is special because it does not cause serious side effects like other...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
PRO Top long ideas returned 21.7% in 2016**
"As a PRO member, we get uniquely valuable perspective that go beyond our quantiative analysis... We rely on PRO to get beyond the numbers quickly and add much needed perspective. It keeps me ahead of the next big thing. - Mark Choate, Malaga Cove Capital"
Mark Choate, Malaga Cove Capital
"Contributors (writers and commentators), often have a long history in the secuirities they opine on and some are clearly well positioned industry participants with detailed industry views that can help provide color on where the skeletons are buried in a particular secuirity and/or industry."
Jim Roumell, Roumell Asset Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details